Laddar...
DRES-04. CHARACTERIZATION OF A MODEL OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA
Despite the discovery and widespread use of the chemotherapeutic drug temozolomide (TMZ), glioblastoma (GBM) remains a fatal cancer. TMZ, a DNA alkylating agent, provides a moderate survival benefit to patients whose tumours do not express the O6-methylguanine-methyltransferase (MGMT) gene. However,...
Sparad:
| I publikationen: | Neuro Oncol |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216400/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.311 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|